CTOs on the Move

United Therapeutics

www.unither.com

 
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. We currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! Our employees can be found collaborating across the United States, Europe and Asia. As a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases.
  • Number of Employees: 250-1000
  • Annual Revenue: $500M-1 Billion
  • www.unither.com
  • 1040 Spring Street
    Silver Spring, MD USA 20910
  • Phone: 877.864.8437

Executives

Name Title Contact Details
Shola Oyewole
Vice President of Digital Innovation Profile
Vicky Ames
Director, Information Security, Risk and Compliance Profile
Jeffrey Kase
Vice President and Chief Information Officer Profile

Similar Companies

Open Mri Of North Fulton Inc

Open Mri Of North Fulton Inc is a Roswell, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PPD Global Central Labs

PPD Global Central Labs is a Newport, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lower Columbia Pathologists

Lower Columbia Pathologists is a Longview, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

X Techs

X Techs is a New Orleans, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nuvectra

Nuvectra™ is a neuromodulation company committed to helping physicians improve the lives of people with chronic conditions through our medical devices. At Nuvectra, we focus not only on what our devices do, but also on reducing their complexity for clinicians and patients. We are committed to developing products with intelligent innovations and technologies that provide improved outcomes and long-term solutions for our customers. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder and deep brain stimulation (DBS) for the treatment of Parkinson`s Disease. NeuroNexus, a subsidiary owned by Nuvectra, designs, manufactures, and markets leading-edge neural-interface technologies for the neuroscience clinical research market.